首页> 外文期刊>Methods: A Companion to Methods in Enzymology >Breast cancer patient stratification using a molecular regularized consensus clustering method
【24h】

Breast cancer patient stratification using a molecular regularized consensus clustering method

机译:使用分子规则的共识分子聚类方法分层乳腺癌患者分层

获取原文
获取原文并翻译 | 示例
           

摘要

Breast cancers are highly heterogeneous with different subtypes that lead to different clinical outcomes including prognosis, response to treatment and chances of recurrence and metastasis. An important task in personalized medicine is to determine the subtype for a breast cancer patient in order to provide the most effective treatment. In order to achieve this goal, integrative genomics approach has been developed recently with multiple modalities of large datasets ranging from genotypes to multiple levels of phenotypes. A major challenge in integrative genomics is how to effectively integrate multiple modalities of data to stratify the breast cancer patients. Consensus clustering algorithms have often been adopted for this purpose. However, existing consensus clustering algorithms are not suitable for the situation of integrating clustering results obtained from a mixture of numerical data and categorical data. In this work, we present a mathematical formulation for integrative clustering of multiple-source data including both numerical and categorical data to resolve the above issue. Specifically, we formulate the problem as a novel consensus clustering method called Molecular Regularized Consensus Patient Stratification (MRCPS) based on an optimization process with regularization. Unlike the traditional consensus clustering methods, MRCPS can automatically and spontaneously cluster both numerical and categorical data with any option of similarity metrics. We apply this new method by applying it on the TCGA breast cancer datasets and evaluate using both statistical criteria and clinical relevance on predicting prognosis. The result demonstrates the superiority of this method in terms of effectiveness of aggregation and differentiating patient outcomes. Our method, while motivated by the breast cancer research, is nevertheless universal for integrative genomics studies.
机译:乳腺癌具有高度异质的,具有不同的亚型,导致不同的临床结果,包括预后,治疗和复发和转移的可能性。个性化药物中的重要任务是确定乳腺癌患者的亚型,以提供最有效的治疗方法。为了实现这一目标,最近已经开发了综合基因组学方法,其中大型数据集的多种方式范围从基因型到多种表型。综合基因组学中的主要挑战是如何有效地整合多种数据模式来分层乳腺癌患者。为此目的经常采用共识群集算法。然而,现有的共识聚类算法不适用于集成从数值数据和分类数据的混合获得的聚类结果的情况。在这项工作中,我们为多源数据的综合聚类提供了一种数学制定,包括数字和分类数据来解决上述问题。具体地,我们根据具有规则化的优化过程,将该问题作为称为分子正规共识患者分层(MRCPS)的新的共识聚类方法。与传统的共识聚类方法不同,MRCPS可以自动和自动地将两个数字和分类数据与相似度量的任何选项进行分类。通过将其在TCGA乳腺癌数据集上应用并使用统计标准进行评估和预测预后的临床相关性来应用这种新方法。结果表明,在聚集的有效性和区分患者结果方面的优越性。我们的方法,而受到乳腺癌研究的激励,仍是综合性基因组学研究的普遍性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号